Search research articles
Contact Us
Filters
Showing results (131-140 of 159) with videos related to
Page
of 16
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1988
Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group
A Roussel, J H Jacob, P Haegele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1996
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study
G Blijham, T Wagener, J Wils, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group
J A Wils, H O Klein, D J Wagener, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1989
Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial
A Roussel, H Bleiberg, O Dalesio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2000
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients
Bensmaïne, A de Gramont, S Brienza, et al.
Anti-Cancer Drugs
|
February 1, 1995
Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group
S J Van Belle, V F Cocquyt, H Bleiberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 1997
Gastrointestinal Tract Cancer Liaison Office: an attempt to organise clinical research in Europe
H Bleiberg, B Gerard, J Wils, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1996
Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group)
P Rougier, C van Pottelsberghe, T Kok, et al.
British Journal of Cancer
|
August 17, 2000
Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups
G Freyer, P Rougier, R Bugat, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy
B Audhuy, P Cappelaere, M Martin, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 159) with videos related to
Sort By:
Page
of 16
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1988
Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group
A Roussel, J H Jacob, P Haegele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1996
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study
G Blijham, T Wagener, J Wils, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group
J A Wils, H O Klein, D J Wagener, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1989
Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial
A Roussel, H Bleiberg, O Dalesio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2000
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients
Bensmaïne, A de Gramont, S Brienza, et al.
Anti-Cancer Drugs
|
February 1, 1995
Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group
S J Van Belle, V F Cocquyt, H Bleiberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 1997
Gastrointestinal Tract Cancer Liaison Office: an attempt to organise clinical research in Europe
H Bleiberg, B Gerard, J Wils, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1996
Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group)
P Rougier, C van Pottelsberghe, T Kok, et al.
British Journal of Cancer
|
August 17, 2000
Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups
G Freyer, P Rougier, R Bugat, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy
B Audhuy, P Cappelaere, M Martin, et al.
Page
of 16